Analysis of NfL and GFAP in Different Dietary Patterns

NCT ID: NCT07312994

Last Updated: 2025-12-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-18

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational study aims to investigate the impact of different dietary patterns on brain tissue biomarkers in healthy young adults by measuring blood levels of NfL and GFAP.

The primary research question is: Do vegan, vegetarian, or omnivorous diets influence NfL and GFAP levels?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neurofilament Light Chain Glial Fibrillary Acidic Protein GFAP Vegan Diet Vegetarian Diet

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Omnivore

No interventions assigned to this group

Vegan

No interventions assigned to this group

Vegetarian

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy individuals who have followed a vegan, vegetarian, or omnivorous diet for at least one consecutive year
* Aged between 18 and 40 years
* Provision of written informed consent

Exclusion Criteria

* Diagnose neurological disorders (e.g. neurodegenerative, inflammatory, autoimmune, infectious, vascular)
* Eating disorders
* Excessive alcohol consumption
* Pregnancy
* Recent moderate to severe infection (within the past 12 weeks) , including SARS-CoV-2
* Recent trauma, injury, or surgery (within the past 12 weeks)
* Significant BMI fluctuations (\>5 points) within the last year
* Patients who have been using Proton pump inhibitors (PPIs) for an extended period (e.g., 1 month).
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medizinische Einrichtungen der Universität Düsseldorf

UNKNOWN

Sponsor Role collaborator

Medizinische Fakultät der Universität zu Köln

UNKNOWN

Sponsor Role collaborator

Universitätsklinkum Münster - Medizinische Klinik und Poliklinik B

OTHER

Sponsor Role collaborator

Salzburger Landeskliniken

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tobias Moser

apl. Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Christian-Doppler-Klinik

Salzburg, Salzburg, Austria

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Austria

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tobias Moser, Prof.

Role: CONTACT

Phone: +435725534720

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Fabio Rossini, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1119/2025

Identifier Type: -

Identifier Source: org_study_id